Mycoplasma pneumoniae Antibodies IgM, Qualitative (Serum)
The study is designed to detect IgM class antibodies to Mycoplasma pneumoniae — the pathogen of atypical respiratory tract infections.
Used for diagnosing acute or recent mycoplasma infection.
Particularly informative in the first weeks of disease, during the period of active immune response, when clinical symptoms are already pronounced but IgG may be absent.
Prescribed when atypical pneumonia, tracheobronchitis, or bronchitis with prolonged course is suspected.
Allows timely confirmation of infection and adjustment of antibacterial therapy.
What the test assesses:
– Presence or absence of IgM class antibodies to Mycoplasma pneumoniae.
– Active phase of the infectious process.
– Recent primary contact of the body with the pathogen.
Biomaterial: Venous blood (serum)
– Submit fasting.
– Drinking still water is allowed.
– It is advisable to exclude physical exertion and stress before blood collection.
Medications:
– It is recommended to submit the test before starting antibacterial therapy, as treatment may affect immune response dynamics.
– Immunoglobulin intake may distort test results.
– When taking any medications, be sure to inform the doctor or indicate them when submitting the test.
Recommended for testing:
– With acute disease onset, fever, dry or persistent cough.
– When atypical pneumonia is suspected or standard therapy is ineffective.
– With prolonged, complicated, or recurring infection course.
– With cough, intoxication, and prolonged fever in children.
– Positive result (IgM detected): indicates acute or recent mycoplasma infection; clinical assessment and treatment are required.
– Negative result (IgM not detected): active infection is unlikely or the examination was conducted at an early stage; if clinically suspected, repeat testing or IgG/PCR determination is recommended.
Important — to improve diagnostic accuracy, comprehensive examination is recommended: IgM + IgG and/or PCR.
